Testing effectiveness (Phase 2)Ended earlyNCT02245412
What this trial is testing
A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease
Who this might be right for
Acute Graft-Versus-Host DiseaseGIGVHD
Alexion Pharmaceuticals, Inc. 25